CLOSE

Laboratory of Haemato-Oncology

highlight

In collaboration with IEO Department of Experimental Oncology the Division is investigating novel preclinical models of human haematological malignancies that are used to investigate new prognostic markers and new therapeutic procedures.

The Division includes the following Units: 

Clinical Haemato-Oncology Stem Cell Unit

 

 

Our Activities

The Laboratory has two main clinical activities, both ISO9001, JACIE and JC Lab certified: 

  1. diagnosis of haematological malignancies
  2. stem cell processing for transplantation.

Since 2011, the lab is also offering cell sorting and purification forclinicians and scientist interested in translational research. In 2013, the lab performed more than 600 cell sorting procedures, more than 70 stem cell collections were processed for autologous or allogeneic use and more than 1,200 blood and marrow sampleswere studied by flow cytometry, PCR, immunohistochemistry, FISH, cytogenetics and circulating tumor-specific DNA. The repository of plasma, serum and whole blood samples from leukaemia, lymphoma and myeloma patients includes nearly 8,000 frozen samples from untreatedpatients at first diagnosis and from patients longitudinally followed after remission or relapse.

We are currently leading an international effort toward the standardization of the measurement of these surrogate markers.

The Division includes the following Unit: Clinical Haemato-Oncology Stem Cell Unit

PARTNERSHIP

Università degli Studi di Milano

MAIN CREDITS

Ministero della Salute Joint Commission International bollinirosa

© 2013 Istituto Europeo di Oncologia - via Ripamonti 435 Milano - P.I. 08691440153 - Codice intermediario fatturazione elettronica: A4707H7

IRCCS - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO